Clopidogrel Bisulfate 75mg Tab (30s, 90s and 500s or 1000s)   3

Background
The solicitation is issued by the Department of Veterans Affairs (VA) and the Department of Defense (DOD) to establish a supply source that will provide pharmaceutical products for purchase through their respective Pharmaceutical Prime Vendor (PPV) Programs. The purpose is to ensure availability and consistency of products for nationwide usage and to obtain volume-based, committed-use pricing. The contract effective date, implementation period, and ordering period are specified in detail.

Work Details
The specific product being solicited is Clopidogrel Bisulfate 75mg Tablet in various quantities (30s, 90s, 500s, and 1000s). Offerors are required to submit prices for the base year and all four one-year options for all line items. Prices offered must not exceed two decimal places and must include a 0.5% Cost Recovery Fee. Additionally, offerors must list an 11-digit National Drug Code (NDC) number for each offered drug that is unique to the offeror's company.

The solicitation also includes detailed packaging requirements for the unit-of-use packaging identified in the Schedule of Supplies.

Period of Performance
The contract will be effective on the date the government signs the SF1449 and notifies the offeror of award. The implementation period will begin on the Contract Effective Date and end at the start of the Ordering Period, with a maximum duration of 60 days if awarded after a specified date. The base year Ordering Period will be in effect for one year.

Place of Performance
Products will be ordered by government entities through Government Prime Vendor contracts, with delivery to multiple destinations or performance at multiple locations as determined between the awarded contractor(s) and Government Prime Vendor contractors.